Vivimed Labs Limited, Established in 1991, has metamorphosed from a domestic small, entrepreneurial family-operated business to a globally renowned supplier of niche molecules and formulations across Healthcare, Pharmaceuticals and Specialty Chemicals consumers in several countries. The company's presence in Active Pharmaceutical Ingredients (API), Finished Dosage Formulation (FDF) and Retail Branded Formulation manufacturing, caters to the inner health of people. Within the FDF business, it provides contract manufacturing services and the manufacture of branded formulations. The active ingredients manufactured by the company are the preferred ingredients in Home & Personal care segments such as hair, skin, oral care and anti-microbial preservatives, by leading global FMCG conglomerates. The company's current product portfolio caters to over 75% of the ingredient market. The company is also present in the Industrial care segments such as, photo chromic dyes and imaging chemicals. The company will soon be expanding its operations into the fast-emerging and highly demanding sector of Printable Electronics and Organic Semiconductors.

Vivimed Labs major competitors are Deccan Health Care, JFL Life Sciences, Dipna Pharma., Murae Organisor, Biofil Chem & Pharma, Makers Laboratories, EVOQ Remedies.
Market Cap of Vivimed Labs is ₹41 Crs.
While the median market cap of its peers are ₹40 Crs.

Vivimed Labs seems to be less financially stable compared to its competitors.
Altman Z score of Vivimed Labs is -0.17 and is ranked 8 out of its 8 competitors.